[go: up one dir, main page]

IS4679A - Bensóþíasólonafleiður - Google Patents

Bensóþíasólonafleiður

Info

Publication number
IS4679A
IS4679A IS4679A IS4679A IS4679A IS 4679 A IS4679 A IS 4679A IS 4679 A IS4679 A IS 4679A IS 4679 A IS4679 A IS 4679A IS 4679 A IS4679 A IS 4679A
Authority
IS
Iceland
Prior art keywords
bensóþíasólonafleiður
Prior art date
Application number
IS4679A
Other languages
English (en)
Inventor
Victor Bonnert Roger
Charles Brown Roger
Alan Cage Peter
Ince Francis
Pairaudeau Garry
Original Assignee
Astrazenenca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9518952.8A external-priority patent/GB9518952D0/en
Priority claimed from GBGB9614346.6A external-priority patent/GB9614346D0/en
Application filed by Astrazenenca Ab filed Critical Astrazenenca Ab
Publication of IS4679A publication Critical patent/IS4679A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/04Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/24Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/12Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IS4679A 1995-09-15 1998-03-04 Bensóþíasólonafleiður IS4679A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9518952.8A GB9518952D0 (en) 1995-09-15 1995-09-15 Compounds
GBGB9614346.6A GB9614346D0 (en) 1996-07-10 1996-07-10 Benzothiazolone derivatives
PCT/GB1996/002247 WO1997010227A1 (en) 1995-09-15 1996-09-12 Benzothiazolone derivatives

Publications (1)

Publication Number Publication Date
IS4679A true IS4679A (is) 1998-03-04

Family

ID=26307771

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4679A IS4679A (is) 1995-09-15 1998-03-04 Bensóþíasólonafleiður

Country Status (28)

Country Link
US (5) US5846989A (is)
EP (1) EP0850232B1 (is)
JP (1) JP3213327B2 (is)
KR (1) KR19990044674A (is)
CN (2) CN1073098C (is)
AR (1) AR004512A1 (is)
AT (1) ATE190610T1 (is)
AU (1) AU706094B2 (is)
BR (1) BR9610316A (is)
CA (1) CA2231003A1 (is)
CY (1) CY2227B1 (is)
CZ (1) CZ74098A3 (is)
DE (1) DE69607183T2 (is)
EE (1) EE03395B1 (is)
ES (1) ES2146901T3 (is)
GR (1) GR3033681T3 (is)
HU (1) HUP9802393A3 (is)
IL (4) IL141954A0 (is)
IS (1) IS4679A (is)
MY (1) MY113518A (is)
NO (1) NO310721B1 (is)
NZ (4) NZ318007A (is)
PL (1) PL325517A1 (is)
PT (1) PT850232E (is)
SK (1) SK282394B6 (is)
TR (1) TR199800457T2 (is)
TW (1) TW356468B (is)
WO (1) WO1997010227A1 (is)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1498124T3 (da) * 1997-10-17 2007-11-05 Ark Therapeutics Ltd Anvendelse af inhibitorer i renin-angiotensinsystemet
SE0004750D0 (sv) * 2000-12-19 2000-12-19 Astrazeneca Ab Novel formulation
GB0218629D0 (en) * 2002-08-09 2002-09-18 Novartis Ag Organic compounds
AR040962A1 (es) * 2002-08-09 2005-04-27 Novartis Ag Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto
CN100569760C (zh) 2003-11-21 2009-12-16 施万制药 具有β2肾上腺素能受体激动剂和毒蕈碱性受体拮抗剂活性的化合物
GB0426164D0 (en) 2004-11-29 2004-12-29 Novartis Ag Organic compounds
UA94235C2 (en) * 2005-08-09 2011-04-26 Астразенека Аб Novel benzothiazolone derivatives
RU2415136C2 (ru) * 2005-08-09 2011-03-27 Астразенека Аб Новые производные бензотиазолона
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200740781A (en) * 2005-08-29 2007-11-01 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
EP2094646A1 (en) * 2006-12-20 2009-09-02 AstraZeneca AB Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases
TW200833670A (en) * 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
UY31905A (es) 2008-06-18 2010-01-29 Astrazeneca Ab Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones.
RU2011101664A (ru) * 2008-06-20 2012-07-27 Астразенека Аб (Se) Фармацевтическая композиция, содержащая 4-гидрокси-2-оксо-2, 3-дигидро-1, 3-бензотиазол-7-ильное соединение, для модулирования активности бета2- адренорецепторов

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314944A (en) * 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
GB8426200D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
US4554284A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones
US4554287A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones
DK514585A (da) * 1984-11-08 1986-05-09 Syntex Inc Aminoethylanilinderivater
DE3728695A1 (de) * 1987-08-25 1989-03-09 Schering Ag Neue benzimidazol-derivate
GB9024208D0 (en) * 1990-11-07 1990-12-19 Salutar Inc Compounds
GB9210632D0 (en) * 1992-05-19 1992-07-01 Fisons Plc Compounds
GB9211172D0 (en) * 1992-05-27 1992-07-08 Fisons Plc Compounds
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines

Also Published As

Publication number Publication date
IL141956A0 (en) 2002-03-10
AU706094B2 (en) 1999-06-10
NO981104D0 (no) 1998-03-12
NO981104L (no) 1998-05-14
PL325517A1 (en) 1998-08-03
AU6937196A (en) 1997-04-01
PT850232E (pt) 2000-08-31
KR19990044674A (ko) 1999-06-25
SK29598A3 (en) 1999-01-11
IL123639A (en) 2002-04-21
DE69607183T2 (de) 2000-11-23
MY113518A (en) 2002-03-30
EE03395B1 (et) 2001-04-16
US5846989A (en) 1998-12-08
CN1356323A (zh) 2002-07-03
JP3213327B2 (ja) 2001-10-02
TR199800457T2 (xx) 1998-07-21
AR004512A1 (es) 1998-12-16
SK282394B6 (sk) 2002-01-07
EE9800069A (et) 1998-10-15
ES2146901T3 (es) 2000-08-16
TW356468B (en) 1999-04-21
CA2231003A1 (en) 1997-03-20
CZ74098A3 (cs) 1998-08-12
IL141955A0 (en) 2002-03-10
NZ332396A (en) 1999-02-25
HK1008781A1 (en) 1999-05-21
US6080869A (en) 2000-06-27
US6008365A (en) 1999-12-28
JPH11512422A (ja) 1999-10-26
IL123639A0 (en) 1998-10-30
HUP9802393A2 (hu) 1999-04-28
CY2227B1 (en) 2003-04-18
MX9801963A (es) 1998-08-30
EP0850232A1 (en) 1998-07-01
EP0850232B1 (en) 2000-03-15
DE69607183D1 (de) 2000-04-20
WO1997010227A1 (en) 1997-03-20
BR9610316A (pt) 1999-07-06
NZ332397A (en) 1999-02-25
IL141954A0 (en) 2002-03-10
ATE190610T1 (de) 2000-04-15
HUP9802393A3 (en) 2000-01-28
NO310721B1 (no) 2001-08-20
CN1073098C (zh) 2001-10-17
NZ318007A (en) 1999-07-29
US5973167A (en) 1999-10-26
CN1202163A (zh) 1998-12-16
NZ332395A (en) 1999-02-25
GR3033681T3 (en) 2000-10-31
US5977384A (en) 1999-11-02

Similar Documents

Publication Publication Date Title
BR9609301A (pt) Cetoenois dialquil-halogenofenil-substituídos
BR9609171A (pt) Fenilpiridazinonas
BR9609324A (pt) Macrolidas
ATA135896A (de) Skibob
BR9607795A (pt) Fucopeptídeos
IS4679A (is) Bensóþíasólonafleiður
DE59606332D1 (de) Benzisothiazolyl-substituierte Aminomethylchromane
BR9605387A (pt) 1-azinil-tetrazolinonas
BR9603509A (pt) Piperidinilmetiloxazolidinonas
ATE198470T1 (de) Alkenyl-benzoylguanidine
ATE240972T1 (de) Cyclopeptolide
BR9605050A (pt) Filatório
BR9611733A (pt) Fluorobutenoiloxiacetamidas
BR9501643A (pt) Helistato
BR9503866A (pt) Autolabor
BR7502025U (pt) Kantil
BR9502123A (pt) Triamplificador
BR7501301U (pt) Guarda-chuva-mochila
BR7501303U (pt) Dupla-embalagem
BR7501399U (pt) Ciclonavegador
BR7501426U (pt) Búlica
BR7501467U (pt) Vassourágua
BR7501485U (pt) Fibropiso
BR7501828U (pt) Multicopo
BR7501298U (pt) Torre-audio-visual